Search results for "dynamic"

showing 10 items of 12329 documents

Quantifying Net Synergy/Redundancy of Spontaneous Variability Regulation via Predictability and Transfer Entropy Decomposition Frameworks.

2017

Objective: Indexes assessing the balance between redundancy and synergy were hypothesized to be helpful in characterizing cardiovascular control from spontaneous beat-to-beat variations of heart period (HP), systolic arterial pressure (SAP), and respiration (R). Methods: Net redundancy/synergy indexes were derived according to predictability and transfer entropy decomposition strategies via a multivariate linear regression approach. Indexes were tested in two protocols inducing modifications of the cardiovascular regulation via baroreflex loading/unloading (i.e., head-down tilt at −25° and graded head-up tilt at 15°, 30°, 45°, 60°, 75°, and 90°, respectively). The net redundancy/synergy of …

AdultMaleMultivariate statisticsComputer scienceEntropyBiomedical EngineeringBlood Pressurecomputer.software_genreAutonomic Nervous System01 natural sciences010305 fluids & plasmasHead-Down TiltEntropy (classical thermodynamics)ElectrocardiographyYoung AdultHeart RateBayesian multivariate linear regression0103 physical sciencesStatisticshead-down tilt (HDT)Redundancy (engineering)Entropy (information theory)HumansPredictabilityEntropy (energy dispersal)010306 general physicsEntropy (arrow of time)cardiovascular controlModels StatisticalEntropy (statistical thermodynamics)heart rate variabilityUnivariateSignal Processing Computer-AssistedBaroreflexMiddle Agedhead-up tilt (HUT)Settore ING-INF/06 - Bioingegneria Elettronica E InformaticaTransfer entropyFemaleData miningWiener-Granger causalitycomputerEntropy (order and disorder)IEEE transactions on bio-medical engineering
researchProduct

Desmopressin in the Treatment of Nocturia: A Double-Blind, Placebo-Controlled Study

2007

Objectives: To investigate efficacy, safety, and impact on quality of sleep of desmopressin in the treatment of nocturia. Methods: Adults aged >= 18 yr with nocturia (>= 2 voids/night) received desmopressin tablets (0.1, 0.2, or 0.4 mg) during a 3-wk dose-titration period. Patients should show sufficient response during the dose-titration period (>= 20% reduction in nocturnal diuresis) and a return of nocturnal diuresis to >= 80% of baseline levels during washout. Eligible patients then entered a 3-wk double-blind treatment period and received either desmopressin or placebo. Results: 127 patients were randomised to either desmopressin (n = 61) or placebo (n = 66). Twenty (33%) desmopressin-…

AdultMaleNephrologymedicine.medical_specialtyUrologyPlacebo-controlled studyAdministration OralDiuresisPlaceboDouble-Blind MethodInternal medicinemedicineHumansNocturiaDeamino Arginine VasopressinDesmopressinAdverse effectAgedAged 80 and overDose-Response Relationship Drugbusiness.industryAntidiuretic AgentsMiddle AgedSurgeryUrodynamicsTreatment OutcomeAnesthesiaFemaleNocturiamedicine.symptomSleepbusinesshormones hormone substitutes and hormone antagonistsFollow-Up Studiesmedicine.drugAntidiureticEuropean Urology
researchProduct

Plasticity of brain wave network interactions and evolution across physiologic states

2015

Neural plasticity transcends a range of spatio-temporal scales and serves as the basis of various brain activities and physiologic functions. At the microscopic level, it enables the emergence of brain waves with complex temporal dynamics. At the macroscopic level, presence and dominance of specific brain waves is associated with important brain functions. The role of neural plasticity at different levels in generating distinct brain rhythms and how brain rhythms communicate with each other across brain areas to generate physiologic states and functions remains not understood. Here we perform an empirical exploration of neural plasticity at the level of brain wave network interactions repre…

AdultMaleNerve netCognitive NeuroscienceNeuroscience (miscellaneous)Sensory systemPlasticityCognitive neurosciencelcsh:RC321-571Young AdultCellular and Molecular NeuroscienceNeuroplasticitymedicineHumanslcsh:Neurosciences. Biological psychiatry. NeuropsychiatryOriginal ResearchSlow-wave sleepCerebral CortexNetwork physiologySleep StagesNeuronal PlasticityBrain WaveBrain wave interactions; Network physiology; Neural plasticity; Sleep; Time delay stability; Adult; Brain Waves; Cerebral Cortex; Female; Humans; Male; Nerve Net; Neuronal Plasticity; Sleep; Young Adult; Neuroscience (miscellaneous); Cellular and Molecular Neuroscience; Sensory Systems; Cognitive NeuroscienceNetwork dynamicsBrain WavesSettore FIS/07 - Fisica Applicata(Beni Culturali Ambientali Biol.e Medicin)Sensory Systemsbrain wave interactionsmedicine.anatomical_structureBrain wave interactionFemaletime delay stabilityNerve NetSensory SystemPsychologySleepNeuroscienceHumanNeuroscienceneural plasticityFrontiers in Neural Circuits
researchProduct

Influence of St John's wort on catecholamine turnover and cardiovascular regulation in humans

2004

BACKGROUND: St John's wort (Hypericum perforatum) is a popular over-the-counter antidepressant. Its antidepressive effect has been attributed in part to inhibition of monoamine transporters and monoamine oxidase, on the basis of in vitro studies. METHODS: In a double-blind, randomized, placebo-controlled, crossover study, 16 healthy subjects (11 men and 5 women; mean age, 31 +/- 5 years) ingested either St John's wort (300 mg three times daily) or placebo for 7 days. Imipramine treatment (50 mg three times daily) in 7 subjects served as a positive control. After treatment, physiologic and biochemical tests included cardiovascular reflex testing, graded head-up tilt testing, and plasma catec…

AdultMaleNitroprussideImipraminemedicine.medical_specialtyPosturePharmacologyAutonomic Nervous SystemPlaceboMethoxyhydroxyphenylglycolNorepinephrine uptakeCardiovascular Physiological PhenomenaNorepinephrineCatecholaminesDouble-Blind MethodInternal medicineHeart rateSupine PositionmedicineHumansNitric Oxide DonorsPharmacology (medical)PeryleneAnthracenesPharmacologyCross-Over StudiesAdrenergic Uptake Inhibitorsbusiness.industryHemodynamicsHypericum perforatumEndocrinologyBlood pressureMonoamine neurotransmitterCatecholamine34-Dihydroxyphenylacetic AcidAntidepressantFemalebusinessHypericummedicine.drugClinical Pharmacology & Therapeutics
researchProduct

Model-based approach to describe G-CSF effects in carboplatin-treated cancer patients.

2013

Granulocyte colony-stimulating factor (G-CSF) is often used in cancer patients receiving cytotoxic drugs to prevent or reduce high grade neutropenia. We propose a pharmacokinetic/pharmacodynamic model to describe myelotoxicity in both G-CSF treated and non-treated patients that shall increase our understanding of G-CSF effects. The model was built from absolute neutrophil counts (ANC) obtained in 375 carboplatin-treated patients, 47 of whom received G-CSF. It includes some prior information on G-CSF taken from the literature. Simulations were performed to understand differences in G-CSF effects and explore the impact of G-CSF formulation. Our model well described the data in all patients. M…

AdultMaleOncologymedicine.medical_specialtyNeutrophilsmedicine.medical_treatment[SDV]Life Sciences [q-bio]Pharmaceutical ScienceAntineoplastic AgentsNeutropeniaModels Biological030226 pharmacology & pharmacyCarboplatinLeukocyte CountYoung Adult03 medical and health scienceschemistry.chemical_compound0302 clinical medicinePharmacokineticsNeoplasmsInternal medicineGranulocyte Colony-Stimulating FactormedicineHumansComputer SimulationPharmacology (medical)Young adultIntensive care medicinePrior informationAgedAged 80 and overPharmacologyChemotherapy[ SDV ] Life Sciences [q-bio]business.industryOrganic ChemistryCancerMiddle Agedmedicine.diseaseCarboplatin3. Good healthchemistry030220 oncology & carcinogenesisPharmacodynamicsMolecular MedicineFemalebusinessBiotechnology
researchProduct

Effects of Stretching on Upper-Body Muscular Performance

2008

The purpose of this investigation was to examine the influence of upper-body static stretching and dynamic stretching on upper-body muscular performance. Eleven healthy men, who were National Collegiate Athletic Association Division I track and field athletes (age, 19.6 +/- 1.7 years; body mass, 93.7 +/- 13.8 kg; height, 183.6 +/- 4.6 cm; bench press 1 repetition maximum [1RM], 106.2 +/- 23.0 kg), participated in this study. Over 4 sessions, subjects participated in 4 different stretching protocols (i.e., no stretching, static stretching, dynamic stretching, and combined static and dynamic stretching) in a balanced randomized order followed by 4 tests: 30% of 1 RM bench throw, isometric ben…

AdultMaleOrthodonticsAMAXUpper bodyRepetition maximumPhysical Therapy Sports Therapy and RehabilitationGeneral MedicineIsometric exerciseAthletic PerformanceBench pressDynamic stretchingUpper ExtremityStatic stretchingMuscle Stretching ExercisesExercise TestHumansOrthopedics and Sports MedicineMuscle SkeletalThrowingMathematicsJournal of Strength and Conditioning Research
researchProduct

Nocturnal oxygen enrichment in sleep apnoea.

2000

We hypothesized that a modest oxygen enrichment, rather than 100% oxygen supplementation as used in previous trials, could result in improvement in ventilatory and cardiac symptoms, in patients with obstructive sleep apnoea (OSA), without jeopardizing the chemostimulant ventilatory drive. This hypothesis was tested in five male patients with OSA in a single-blinded trial consisting of one night spent sleeping in control room air (control night), followed by one night spent sleeping while exposed to air with a 9% enriched oxygen content (oxygen-enriched night). Oxygen enrichment resulted in a significant shift in the oxygen saturation profile towards values of ≥ 95% and to decrease desatura…

AdultMaleOxygen enrichmentmedicine.medical_treatmentchemistry.chemical_elementHemodynamics030204 cardiovascular system & hematologyNocturnalBiochemistryOxygen03 medical and health sciences0302 clinical medicineOxygen therapyMedicineHumansIn patientOxygen saturation (medicine)Sleep Apnea Obstructivebusiness.industryBiochemistry (medical)Cell BiologyGeneral MedicineMiddle AgedSleep in non-human animalsVentilationCircadian RhythmOxygenAffectchemistry030220 oncology & carcinogenesisAnesthesiabusinessThe Journal of international medical research
researchProduct

Photodynamic therapy of nodular basal cell carcinoma with multifiber contact light delivery.

2006

To overcome the limited treatment depth of superficial photodynamic therapy we investigate interstitial light delivery. In the present work the treatment light was delivered using a system in which three or six clear-cut fibers were placed in direct contact with the tumor area. This placement was thought to represent a step toward general purpose interstitial PDT. Twelve nodular basal cell carcinomas were treated employing delta-aminolevulinic acid and 635 nm laser irradiation. Fluorescence measurements were performed monitoring the buildup and subsequent bleaching of the produced sensitizer protoporphyrin IX. The treatment efficacy, judged at a 28-month follow-up, showed a 100% complete re…

AdultMalePathologymedicine.medical_specialtySkin NeoplasmsHealth Toxicology and Mutagenesismedicine.medical_treatmentNodular basal cell carcinomaProtoporphyrinsPhotodynamic therapyToxicologyLight deliveryFluorescencePathology and Forensic Medicinechemistry.chemical_compoundCarcinomamedicineHumansComplete responseAgedPhotosensitizing AgentsProtoporphyrin IXbusiness.industryLasersGeneral MedicineAminolevulinic AcidMiddle Agedmedicine.diseaseTreatment efficacyGeneral purposechemistryPhotochemotherapyCarcinoma Basal CellFemalebusinessNuclear medicineJournal of environmental pathology, toxicology and oncology : official organ of the International Society for Environmental Toxicology and Cancer
researchProduct

Associations of Birth Weight and Postnatal Weight Gain With Cardiometabolic Risk Parameters at 5 Years of Age

2014

The present prospective study assessed the impact of birth weight (BW) and postnatal weight gain on blood pressure and metabolic profile during the first 5 years of life. One hundred thirty-nine newborns (63 women) born at term after uncomplicated pregnancies and in the absence of perinatal illness were included. Subjects were divided according to size at birth in small, appropriate, and large for gestational age. After the initial evaluation on the second day of life, infants were followed up at 6 months and 2 and 5 years. Anthropometric parameters and blood pressure were measured at each visit and metabolic assessment was performed at 5 years of age. Among the BW groups, mothers did not d…

AdultMalePediatricsmedicine.medical_specialtyBirth weightPhysiologyHemodynamicsBlood PressureGestational AgeWeight GainBody Mass Indexchemistry.chemical_compoundRisk FactorsInternal MedicinemedicineBirth WeightHumansInsulinMetabolomicsProspective StudiesProspective cohort studyTriglyceridesPregnancybusiness.industryInfant NewbornInfantGestational ageCholesterol LDLmedicine.diseaseUric AcidBlood pressurechemistryChild PreschoolLinear ModelsUric acidFemalemedicine.symptombusinessWeight gainFollow-Up StudiesHypertension
researchProduct

Pharmacokinetics, pharmacodynamics, and safety of moss-aGalactosidase A in patients with Fabry disease.

2019

Moss-aGalactosidase A (moss-aGal) is a moss-derived version of human α-galactosidase developed for enzyme replacement therapy in patients with Fabry disease. It exhibits a homogenous N-glycosylation profile with >90% mannose-terminated glycans. In contrast to mammalian cell produced α-galactosidase, moss-aGal does not rely on mannose-6-phosphate receptor mediated endocytosis but targets the mannose receptor for tissue uptake. We conducted a phase 1 clinical trial with moss-aGal in six patients with confirmed diagnosis of Fabry disease during a 28-day schedule. All patients received a single dose of 0.2 mg/kg moss-aGal by i.v.-infusion. Primary endpoints of the trial were safety and pharmaco…

AdultMalePhases of clinical researchPharmacologyExcretion03 medical and health sciencesPharmacokineticsGermanyGeneticsmedicineHumansEnzyme Replacement TherapyInfusions IntravenousGenetics (clinical)030304 developmental biology0303 health sciencesKidneySphingolipidsbusiness.industry030305 genetics & heredityEnzyme replacement therapyMiddle Agedmedicine.diseaseFabry diseasemedicine.anatomical_structureTreatment OutcomePharmacodynamicsalpha-GalactosidaseFabry DiseaseFemaleGlycolipidsbusinessMannose receptorJournal of inherited metabolic disease
researchProduct